| human | Q5 |
| P6178 | Dimensions author ID | 0661440166.43 |
| P496 | ORCID iD | 0000-0003-2044-1754 |
| P1153 | Scopus author ID | 35993775100 |
| P10861 | Springer Nature person ID | 0661440166.43 |
| P108 | employer | University of Sheffield | Q823917 |
| P734 | family name | Cross | Q2672029 |
| Cross | Q2672029 | ||
| Cross | Q2672029 | ||
| P735 | given name | Simon | Q4117588 |
| Simon | Q4117588 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| P2031 | work period (start) | 1989-01-01 |
| Q36133122 | 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model' |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q73500251 | A 1 mm depressed type IIC minute colorectal cancer: first reported case and discussion of clinical relevance, with special reference to endoscopic diagnosis |
| Q37052173 | A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients |
| Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
| Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q44814295 | A prospective study of duodenal bulb biopsy in newly diagnosed and established adult celiac disease |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q50803599 | A zebrafish model to study and therapeutically manipulate hypoxia signaling in tumorigenesis. |
| Q46941548 | Achieving R0 resection in the colorectum using endoscopic submucosal dissection |
| Q24563593 | Acp. Best practice no 155. Pathological investigation of deaths following surgery, anaesthesia, and medical procedures |
| Q37424111 | Activation and clinical significance of the unfolded protein response in breast cancer |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q61758655 | An automated pattern recognition system for the quantification of inflammatory cells in hepatitis-C-infected liver biopsies |
| Q49058397 | Angiogenesis induction and regression in human surgical wounds. |
| Q37330662 | Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. |
| Q53062138 | Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds. |
| Q54563937 | Angiopoietins 1 and 2 and Tie-2 receptor expression in human ductal breast disease. |
| Q41486963 | Antibody negative coeliac disease presenting in elderly people--an easily missed diagnosis |
| Q52300170 | Application of the fuzzy ARTMAP neural network model to medical pattern classification tasks. |
| Q61758659 | Aptitude testing and assessment of training progress in histopathology |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q39404806 | Assessment of specimen fixation in a surgical pathology service |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q39595084 | Audit of the histopathological diagnosis of non-neoplastic colorectal biopsies: achievable standards for the diagnosis of inflammatory bowel disease |
| Q40036881 | BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q61758644 | Blood vessel characterization in human dermal wound repair and scarring |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q43163142 | Breast carcinomas diagnosed in the 1980s |
| Q40592177 | Bulb Biopsy in Adult Celiac Disease: Pros Outweigh the Cons? |
| Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
| Q40669226 | Chaos and antichaos in pathology |
| Q24317487 | Characterisation and expression of SPLUNC2, the human orthologue of rodent parotid secretory protein |
| Q37192534 | Chromoscopic endomicroscopy: in vivo cellular resolution imaging of the colorectum |
| Q40031740 | Clinical and Immunologic Features of Ultra-Short Celiac Disease |
| Q35596761 | Colonoscopic resection of lateral spreading tumours: a prospective analysis of endoscopic mucosal resection |
| Q61758638 | Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q46810172 | Confocal chromoscopic endomicroscopy is superior to chromoscopy alone for the detection and characterisation of intraepithelial neoplasia in chronic ulcerative colitis |
| Q33293784 | Confocal endomicroscopy in ulcerative colitis: differentiating dysplasia-associated lesional mass and adenoma-like mass |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q61758669 | Correspondence Re: Sharifi S, Peterson MK, Maum JK, Raza S, Schnitt SJ. Assessment of Pathologic Prognostic Factors in Breast Core Needle Biopsies. Mod Pathol 1999; 12: 941–5 |
| Q68164623 | Correspondence re: G. J. Laroye and S. Minkin. The impact of mitotic index on predicting outcome in breast carcinoma: a comparison of different counting methods in patients with different lymph node status. Mod Pathol 4:456, 1991 |
| Q30660858 | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer |
| Q68094610 | Cytological grading of breast carcinomas |
| Q40183857 | DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer |
| Q36184373 | Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis. |
| Q61758678 | Delay in fixation does not affect the immunoreactivity of proliferating cell nuclear antigen (PCNA) |
| Q35596320 | Detecting diminutive colorectal lesions at colonoscopy: a randomised controlled trial of pan-colonic versus targeted chromoscopy |
| Q39035278 | Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line |
| Q46482917 | Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo. |
| Q24649836 | Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis |
| Q32061776 | Discriminant histological features in the diagnosis of chronic idiopathic inflammatory bowel disease: analysis of a large dataset by a novel data visualisation technique |
| Q57565273 | Distinct patterns of microsatellite instability are seen in tumours of the urinary tract |
| Q35185855 | Do pathologists have extrasensory perception? |
| Q39647551 | Does delay in fixation affect the number of mitotic figures in processed tissue? |
| Q50921393 | Does funeral preference influence clinical necropsy request outcome? |
| Q91873905 | Dr Dennis Cotton 1939-2019 |
| Q61758640 | Duodenal bulb biopsies for diagnosing adult celiac disease: is there an optimal biopsy site? |
| Q40466245 | Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. |
| Q39274601 | Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer |
| Q46769272 | EMR using dextrose solution versus sodium hyaluronate for colorectal Paris type I and 0-II lesions: a randomized endoscopist-blinded study |
| Q68876079 | Effect of delayed fixation in the assessment of tumour cell proliferation |
| Q35598257 | Efficacy of high magnification chromoscopic colonoscopy for the diagnosis of neoplasia in flat and depressed lesions of the colorectum: a prospective analysis |
| Q61758647 | Eight-plex iTRAQ analysis of variant metastatic human prostate cancer cells identifies candidate biomarkers of progression: An exploratory study |
| Q51625952 | Endoscopic morphological anticipation of submucosal invasion in flat and depressed colorectal lesions: clinical implications and subtype analysis of the kudo type V pit pattern using high-magnification-chromoscopic colonoscopy. |
| Q35953822 | Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? |
| Q46814603 | Endoscopic mucosal resection for lateral spreading tumors of the colorectum: further randomized studies are required |
| Q52851616 | Endoscopic resection of adenoma-like mass in chronic ulcerative colitis using a combined endoscopic mucosal resection and cap assisted submucosal dissection technique. |
| Q33288626 | Endostatin gene variation and protein levels in breast cancer susceptibility and severity |
| Q45190980 | Eosinophilic colitis complicating anti-epileptic hypersensitivity syndrome: an indication for colonoscopy? |
| Q42386729 | Erratum to: 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'. |
| Q41252522 | Estimating mitotic activity in tumours |
| Q61758672 | Evaluating a neural network decision-support tool for the diagnosis of breast cancer |
| Q36242431 | Evaluating the reliability of causes of death in published clinical research |
| Q52241068 | Evaluation of a statistically derived decision tree for the cytodiagnosis of fine needle aspirates of the breast (FNAB). |
| Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
| Q53346892 | Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma. |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
| Q53360582 | Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. |
| Q39921521 | Expression of beta-dystroglycan is reduced or absent in many human carcinomas |
| Q61758645 | Expression of class 3 semaphorins and their receptors in human breast neoplasia |
| Q35769514 | Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours |
| Q35770122 | Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological |
| Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q61758673 | Fractal Geometric Analysis of the Renal Arterial Tree in Infants and Fetuses |
| Q42515856 | Fractal and integer-dimensional geometric analysis of pigmented skin lesions |
| Q61758675 | Fractal geometric analysis of colorectal polyps |
| Q61758676 | Fractal geometric analysis of material from molar and non-molar pregnancies |
| Q41534922 | Fractals in pathology |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q37215357 | Funeral directors, mortuaries and necropsies: implications for necropsy consent rates and the prevention of infection |
| Q38795484 | GENE EXPRESSION PROFILING AND EXPANDED IMMUNOHISTOCHEMISTRY TESTS TO GUIDE SELECTION OF CHEMOTHERAPY REGIMENS IN BREAST CANCER MANAGEMENT: A SYSTEMATIC REVIEW. |
| Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
| Q33589487 | Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q52905632 | Grading and scoring in histopathology. |
| Q61758646 | Grading in histopathology |
| Q43085920 | Grading system for inflammation in ulcerative colitis |
| Q37110444 | Has there been an information explosion in histopathology? |
| Q37261661 | Have declining clinical necropsy rates reduced the contribution of necropsy to medical research? |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
| Q36547888 | Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers |
| Q43005306 | High magnification chromoscopic colonoscopy as a screening tool in acromegaly |
| Q30492850 | High magnification chromoscopic colonoscopy or high frequency 20 MHz mini probe endoscopic ultrasound staging for early colorectal neoplasia: a comparative prospective analysis |
| Q53555489 | High-magnification chromoscopic colonoscopy: caution needs to be exercised before changing screening policy. |
| Q53632049 | High-magnification chromoscopic ileoscopy in familial adenomatous polyposis: detection in vivo of colonic metaplasia and microadenoma formation. |
| Q51552788 | High-magnification chromoscopic pouchoscopy: a novel in vivo technique for surveillance of the anal transition zone and columnar cuff following ileal pouch-anal anastomosis. |
| Q61758648 | How to design and use a research database |
| Q40069241 | Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A. |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q52259194 | Image analysis of low magnification images of fine needle aspirates of the breast produces useful discrimination between benign and malignant cases. |
| Q33300769 | In vivo confocal laser scanning chromo-endomicroscopy of colorectal neoplasia: changing the technological paradigm |
| Q33322903 | In vivo real-time confocal laser scanning endomicroscopic colonoscopy for the detection and characterization of colorectal neoplasia |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q50482059 | Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. |
| Q40437303 | Inflammation decreases keratin level in ulcerative colitis; inadequate restoration associates with increased risk of colitis-associated cancer |
| Q51915973 | Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. |
| Q34996647 | Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q36340848 | Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension |
| Q33250259 | Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. |
| Q52326620 | Introduction to neural networks. |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q61758679 | Is the grading of breast carcinomas affected by a delay in fixation? |
| Q37116733 | Is the informational content of histopathological reports increasing? |
| Q37247106 | Is there any justification for the routine examination of bowel resection margins in colorectal adenocarcinoma? |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q59089540 | LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia |
| Q40302198 | Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q36087198 | Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and "BRCA-Like" Status, in Both Blood and Tumour DNA. |
| Q39480902 | Loss of dystroglycan function in oesophageal cancer |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q47269753 | Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing |
| Q61758671 | Matrix metalloproteinase levels are elevated in inflammatory bowel disease |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q61758656 | Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q43079184 | Microvascular endothelial cell responses in vitro and in vivo: modulation by zoledronic acid and paclitaxel? |
| Q34015159 | Much of the variation in breast pathology quality assurance data in the UK can be explained by the random order in which cases arrive at individual centres, but some true outliers do exist. |
| Q61758650 | Multinucleated giant cells in enlarged axillary lymph nodes |
| Q61758635 | Neoadjuvant Chemotherapy with or without Zoledronic Acid in Early Breast Cancer--A Randomized Biomarker Pilot Study |
| Q61758677 | Nm23 ‘anti-metastatic’ gene product expression in colorectal carcinoma |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q39090168 | Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer |
| Q35398756 | Observer accuracy in estimating proportions in images: implications for the semiquantitative assessment of staining reactions and a proposal for a new system |
| Q43011596 | Offline telepathology diagnosis of colorectal polyps: a study of interobserver agreement and comparison with glass slide diagnoses |
| Q41111456 | On the origins of mitosis and why it is involved in cancer |
| Q40374890 | Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival? |
| Q61758658 | Osteoprotegerin (OPG)-a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis? |
| Q52838663 | Outcome of elective withdrawal of anti-tumour necrosis factor-α therapy in patients with Crohn's disease in established remission. |
| Q46788939 | Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma |
| Q36601447 | Ownership and uses of human tissue: does the Nuffield bioethics report accord with opinion of surgical inpatients? |
| Q56785074 | Ownership and uses of human tissue: what are the opinions of surgical in-patients? |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q36184231 | PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. |
| Q55046342 | Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate? |
| Q36873786 | Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q24670453 | Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q72730293 | Progress in computer-generated three-dimensional reconstruction |
| Q40397893 | Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer. |
| Q51033077 | Promoter hypermethylation identifies progression risk in bladder cancer. |
| Q53360022 | Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. |
| Q61758651 | Prostate cancer: a systems approach overview |
| Q31135828 | Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q70506615 | Quantitation of the renal arterial tree by fractal analysis |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q37098488 | Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumonia |
| Q39397405 | Reassessment of the rate of fixative diffusion |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
| Q36025869 | Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis |
| Q38338396 | S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors |
| Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
| Q47855911 | SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype |
| Q61758652 | Salvage endoscopic submucosal dissection for residual or local recurrent intraepithelial neoplasia in the colorectum: a prospective analysis |
| Q39454909 | Should eye protection be worn when performing necropsies? |
| Q42345687 | Standardisation of breast tissue fixation procedures |
| Q33593016 | Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies |
| Q61758667 | Supporting decisions in clinical medicine: neural networks in lower gastrointestinal haemorrhage |
| Q43085890 | Survival for colorectal cancer |
| Q39822665 | Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model. |
| Q73600875 | Symptomatic giardiasis without diarrhea: further evidence to support the routine duodenal biopsy? |
| Q61758653 | TMPRSS2 fusions in prostate cancer |
| Q34765948 | Telepathology: current status and future prospects in diagnostic histopathology |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q40032719 | The Polycomb Group protein EZH2 regulates actin polymerization in human prostate cancer cells |
| Q36023363 | The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer |
| Q40107051 | The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers |
| Q40694090 | The application of fractal geometric analysis to microscopic images |
| Q39412131 | The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000-2015). |
| Q37223560 | The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas |
| Q41110348 | The fractal dimension may be a useful morphometric discriminant in histopathology |
| Q61758661 | The molecular pathology of new anti-cancer agents |
| Q35592458 | The role of flat and depressed colorectal lesions in colorectal carcinogenesis: new insights from clinicopathological findings in high-magnification chromoscopic colonoscopy |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q31150087 | The use of digital imaging, video conferencing, and telepathology in histopathology: a national survey |
| Q61758674 | To the editor |
| Q72304631 | Trabecular bone does not have a fractal structure on light microscopic examination |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q61758654 | Tumour heterogeneity and the assessment of expression of proteins for targeted biological therapies |
| Q67779773 | Unrecognised HIV related deaths |
| Q52068177 | Validation of a decision support system for the cytodiagnosis of fine needle aspirates of the breast using a prospectively collected dataset from multiple observers in a working clinical environment. |
| Q52138289 | Visualisation of biomedical datasets by use of growing cell structure networks: a novel diagnostic classification technique. |
| Q21284411 | WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung |
| Q52164947 | What levels of agreement can be expected between histopathologists assigning cases to discrete nominal categories? A study of the diagnosis of hyperplastic and adenomatous colorectal polyps. |
| Q71480730 | Why pathologists should not take fine needle aspirates |
| Q21134794 | iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer |
| Q40018983 | iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression. |
| Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Search more.